EN

A new concept for modelling the number of cancer patients potentially treated in the Czech Republic

DUŠEK, Ladislav, Tomáš PAVLÍK, Eva GELNAROVÁ, Jan MUŽÍK, Jana KOPTÍKOVÁ, Jitka ABRAHÁMOVÁ, Rostislav VYZULA a Jiří VORLÍČEK. A new concept for modelling the number of cancer patients potentially treated in the Czech Republic. In TIES 2007. 2007. ISBN 978-80-210-4333-6.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název A new concept for modelling the number of cancer patients potentially treated in the Czech Republic
Název česky Modelování počtu potenciálně léčených onkologických pacientů v ČR
Název anglicky A new concept for modelling the number of cancer patients potentially treated in the Czech Republic
Autoři DUŠEK, Ladislav, Tomáš PAVLÍK, Eva GELNAROVÁ, Jan MUŽÍK, Jana KOPTÍKOVÁ, Jitka ABRAHÁMOVÁ, Rostislav VYZULA a Jiří VORLÍČEK.
Vydání TIES 2007, 2007.
Další údaje
Originální jazyk čeština
Typ výsledku Prezentace na konferencích
Obor 3.2 Clinical medicine
Stát vydavatele Česká republika
Utajení není předmětem státního či obchodního tajemství
Organizační jednotka Lékařská fakulta
ISBN 978-80-210-4333-6
Klíčová slova anglicky modelling; cancer prevalence; cancer survival; cancer incidence
Štítky cancer incidence, cancer prevalence, cancer survival, Modelling
Změnil Změnil: RNDr. Tomáš Pavlík, Ph.D., učo 52483. Změněno: 30. 6. 2008 12:43.
Anotace
The approach combines epidemiological trends in incidence and prevalence with demographic databases (used for estimates of relative X-yrs survival) and with cancer-specific mortality data that were applied to estimate the rate of dissemination relapses of the disease. The functionality and power of the model is well documented on Czech National Cancer Registry with more than 1,4 million of cases reported since 1977. Long-term history of the registry allows even 30-yrs relative survival estimates with mortality data separating death events due to cancer from the other reasons. Finally, summed numbers of patents that are probable to be treated in a given year are supported with reasonable confidence limits. All estimates are performed in age-specific format with respect to the clinical stage of the patients.
Anotace anglicky
The approach combines epidemiological trends in incidence and prevalence with demographic databases (used for estimates of relative X-yrs survival) and with cancer-specific mortality data that were applied to estimate the rate of dissemination relapses of the disease. The functionality and power of the model is well documented on Czech National Cancer Registry with more than 1,4 million of cases reported since 1977. Long-term history of the registry allows even 30-yrs relative survival estimates with mortality data separating death events due to cancer from the other reasons. Finally, summed numbers of patents that are probable to be treated in a given year are supported with reasonable confidence limits. All estimates are performed in age-specific format with respect to the clinical stage of the patients.
VytisknoutZobrazeno: 20. 4. 2019 18:58

Další aplikace